Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 119

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 119
---
 to be beneficially owned and outstanding for purposes of computing the percentage beneficially owned by any other person. The applicable percentages of stock outstanding as of March 24, 2025 is based upon 562,213 shares of common stock and 17.488 shares of Series A Preferred Stock outstanding on that date. 

 63Table of Contents

Beneficial Ownership 

Name ofBeneficialOwner Shares ofCommonStockBeneficiallyOwned  Percentageof CommonStockBeneficiallyOwned Shares ofSeries APreferredStockBeneficiallyOwned  Percentageof Series APreferredStockBeneficiallyOwned Francois Michelon  66(1) *  -   - Michael Thornton  99(2) *  -   - Irina Pestrikova  5(3) *        Louis Basenese  7(4) *  -   - Anthony DiGiandomenico  68(5) *  -   - Michael Harsh  11(6) *  -   - Alexander Tokman  14(7) *  -   - Richard Jacroux  -           All directors and executive officers as a group (6 persons)  197  *  -   - 5% Stockholders:              Juan R. Rivero (8)        17.488   100%

* Less than one percent.

(1)Consists of 3 share of common stock, 63 shares of common stock issuable upon the exercise of options that are presently exercisable within 60 days of March 24, 2025(2)Consists of 20 shares of common stock, 79 shares of common stock issuable upon the exercise of options that are presently exercisable or becoming exercisable within 60 days of March 24, 2025.(3)Consists of 5 shares of common stock issuable upon the exercise of options that are presently exercisable or becoming exercisable within 60 days of March 24, 2025.(4)Consists of 1 shares of common stock and 6 shares of common stock issuable upon the exercise of options that are presently exercisable or becoming exercisable within 60 days of March 24, 2025.(5)Consists of 59 shares of common stock, 9 shares of